Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The false link between Tylenol and autism

Anonymous
Policy
October 5, 2025
Share
Tweet
Share

The 9/22 White House press conference regarding acetaminophen raises two serious concerns. First, the scientific accuracy of the purported link between acetaminophen and Autism Spectrum Disorder (ASD) is dubious. Additionally, the norms of public communication concerning whether a President should offer medical advice existed for good reason. The heads of CMS, NIH, and FDA were present, but did not dispute in real time the essential claim that Tylenol causes autism.

Second, only someone who has stood at the bedside of a six-year-old in coma with off-the-charts liver enzymes, or a family with an empty chair at the table and a wedding not attended, can fully appreciate the horror that is Reye syndrome. The President did not limit his assertions to use of the drug by pregnant women. He implied it could cause autism when given to babies and children, saying, “[t]aking Tylenol is not good.” It sounded like an unscripted remark, perhaps not so dissimilar to comments about disinfectants and sunlight as treatments for COVID which were likewise not fact-checked by the physicians in the room in real-time.

After the press conference ACOG reaffirmed its longstanding guidance: Acetaminophen remains first-line in pregnancy, used judiciously at the lowest effective dose for the shortest time in consultation with an obstetrician. The AAP also reaffirmed its guidance that acetaminophen is safe for children when taken as directed.

Association is not causation.

The core scientific claim cited in the press conference, based on the Prada et al., meta-analysis of observational studies, conflates association with causation. Observational studies can identify correlations but cannot establish causality. For instance, some believe wearing baseball caps causes baldness, but bald men wear caps to cover their heads. Correlation not causation. Plus, both baseball caps and baldness are common, the fallacy of ubiquity. It is easy to establish a correlation between common things. All cancer victims wear shoes but wearing shoes does not cause cancer.

President Trump’s examples, Cubans and the Amish allegedly do not take acetaminophen and do not have ASD, suffer from the same correlation/causation flaw. Both groups differ from the U.S. population in countless ways unrelated to acetaminophen use. Further, the claim that Cubans do not take acetaminophen is inaccurate; they take paracetamol, the same compound under a different name.

And Cubans suffer from autism at the same rate as other low- and middle-income countries, whose lower reported prevalence probably reflects underdiagnosis and underreporting. Acetaminophen/paracetamol use also varies by country, but that variation does not correlate with autism prevalence and high-quality studies do not support a causal link.

Scientific evidence remains weak.

Gold-standard science does not infer causal relationships from circumstantial evidence. The Prada meta-analysis, published in a less widely cited journal, represents observational data that may suggest associations but cannot justify policy-level claims of causation. Furthermore, Prada et al’s recommendation basically reflected the ACOG guidance—not complete avoidance. The use of this study to support blanket warnings to avoid acetaminophen ignores the established benefits of fever and pain management during pregnancy in addition to the key findings of the research, i.e., to take the lowest possible dose for the shortest possible time.

Historical and epidemiological context

Acetaminophen has been recommended for pain and fever in pregnancy for decades, while the sharp rise in autism diagnoses occurred in the 1990s and 2000s. Before the first use of the term autism in 1943, children exhibiting autistic traits were often diagnosed with childhood schizophrenia, intellectual disability or other developmental disorders. Autism likely existed for generations before acetaminophen came into widespread OTC use in the 1950s.

The Bradford Hill criteria are the epidemiologic equivalent of Koch’s postulates: heuristics for determining causation when controlled experiments aren’t possible. The one indispensable criterion is temporality: The cause must precede the effect. The timeline alone undermines any claim that acetaminophen causes autism and violates the one indispensable Bradford Hill criterion for establishing causation. Increased awareness and broadened diagnostic criteria, rather than biologic factors, almost certainly explain the so-called autism “epidemic.”

Reye syndrome

The claim that acetaminophen use by children causes autism sets the stage for the rebirth of Reye syndrome, a mysterious cause of coma, liver failure and death in children that plagued the world for generations until research proved it was linked to the use of aspirin for febrile illnesses, particularly influenza and varicella. Parents stopped using aspirin and the incidence of Reye syndrome dropped by 90 percent between 1980 and 1987. It essentially disappeared from the face of the Earth. The average U.S. physician was ten years old when the disease became a factoid and knows it only as a board exam question and the reason we don’t give aspirin to kids with viral illnesses.

The rhetoric about the use of acetaminophen in pregnancy risks a spillover into a general aversion to the use of acetaminophen in children. Compounding the problem, the leader of the free world stood at his bully pulpit and apparently just winging it said, “Don’t give Tylenol to the baby after the baby’s born.” He has since ranted on Truth Social, “DON’T GIVE TYLENOL TO YOUR YOUNG CHILD FOR VIRTUALLY ANY REASON.”

ADVERTISEMENT

If parents return to aspirin for childhood fevers, we flirt with re-creating the exact conditions that once caused Reye syndrome to devastate families. Public health authorities would have to emphasize using the safer, but more expensive, ibuprofen instead. But who trusts the public health authorities anymore since they now have a deserved reputation for propagating misinformation. We risk seeing a return of this devastating condition.

Conclusion

The association between Reye syndrome and the use of aspirin is real; the purported link between acetaminophen and autism is not supported by any credible evidence. A simple test for evaluating public medical advice: The speaker should at least have done enough homework to be able to pronounce the medication in question. In this case, that basic standard was not met. The scientific evidence does not support the claims made in the press conference. Advising pregnant women, and children, to avoid acetaminophen entirely is both scientifically unfounded and potentially harmful. Clear, evidence-based communication is essential to maintain public trust and safeguard maternal and child health.

The authors are anonymous physicians and a health care outcomes researcher.

Prev

The paradox of letting your children go

October 5, 2025 Kevin 0
…
Next

Stop trying to lead doctors like corporate employees

October 5, 2025 Kevin 0
…

Tagged as: Pediatrics

Post navigation

< Previous Post
The paradox of letting your children go
Next Post >
Stop trying to lead doctors like corporate employees

ADVERTISEMENT

More by Anonymous

  • When racism findings challenge institutional narratives

    Anonymous
  • Restoring clinical judgment through medical education reform

    Anonymous
  • Gender bias in medicine: Who deserves to be saved?

    Anonymous

Related Posts

  • The answer to hate speech or false speech is not censorship

    Mary Tipton, MD
  • In the crosshairs: The False Claims Act’s new targets in health care

    Scott Ellner, DO, MPH
  • Prescribing data and efficiency: Harnessing technology to alleviate the physician shortage in the U.S.

    Patrick Hunt, MD, MBA
  • How fee-for-service shapes your doctor’s decisions

    Jonathan Staloff, MD & Joseph H. Joo, MD & Joshua Liao, MD
  • Think twice before prescribing opioids as a first-line treatment for pain

    Gary Call, MD
  • Merging the wisdom of pain medicine and addiction medicine to optimize outcomes

    Julie Craig, MD

More in Policy

  • Why private equity is betting on employer DPC over retail

    Dana Y. Lujan, MBA
  • Why PBM transparency rules aren’t enough to lower drug prices

    Armin Pazooki
  • Emergency department metrics vs. reality: Why the numbers lie

    Marilyn McCullum, RN
  • Black women’s health resilience: the hidden cost of “pushing through”

    Latesha K. Harris, PhD, RN
  • FDA loosens AI oversight: What clinicians need to know about the 2026 guidance

    Arthur Lazarus, MD, MBA
  • Why the U.S. health care system is failing patients and physicians

    John C. Hagan III, MD
  • Most Popular

  • Past Week

    • Alex Pretti: a physician’s open letter defending his legacy

      Mousson Berrouet, DO | Physician
    • The hidden costs of the physician non-clinical career transition

      Carlos N. Hernandez-Torres, MD | Physician
    • ADHD and cannabis use: Navigating the diagnostic challenge

      Farid Sabet-Sharghi, MD | Conditions
    • AI-enabled clinical data abstraction: a nurse’s perspective

      Pamela Ashenfelter, RN | Tech
    • Why private equity is betting on employer DPC over retail

      Dana Y. Lujan, MBA | Policy
    • Leading with love: a physician’s guide to clarity and compassion

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
  • Recent Posts

    • Blaming younger doctors for setting boundaries ignores the broken system [PODCAST]

      The Podcast by KevinMD | Podcast
    • Nervous system dysregulation vs. stress: Why “just relaxing” doesn’t work

      Claudine Holt, MD | Physician
    • U.S. opioid policy history: How politics replaced science in pain care

      Richard A. Lawhern, PhD & Stephen E. Nadeau, MD | Meds
    • Alex Pretti’s death: Why politics belongs in emergency medicine

      Marilyn McCullum, RN | Conditions
    • Women in health care leadership: Navigating competition and mentorship

      Sarah White, APRN | Conditions
    • Senior financial scams: a guide for primary care physicians

      John C. Hagan III, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Alex Pretti: a physician’s open letter defending his legacy

      Mousson Berrouet, DO | Physician
    • The hidden costs of the physician non-clinical career transition

      Carlos N. Hernandez-Torres, MD | Physician
    • ADHD and cannabis use: Navigating the diagnostic challenge

      Farid Sabet-Sharghi, MD | Conditions
    • AI-enabled clinical data abstraction: a nurse’s perspective

      Pamela Ashenfelter, RN | Tech
    • Why private equity is betting on employer DPC over retail

      Dana Y. Lujan, MBA | Policy
    • Leading with love: a physician’s guide to clarity and compassion

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
  • Recent Posts

    • Blaming younger doctors for setting boundaries ignores the broken system [PODCAST]

      The Podcast by KevinMD | Podcast
    • Nervous system dysregulation vs. stress: Why “just relaxing” doesn’t work

      Claudine Holt, MD | Physician
    • U.S. opioid policy history: How politics replaced science in pain care

      Richard A. Lawhern, PhD & Stephen E. Nadeau, MD | Meds
    • Alex Pretti’s death: Why politics belongs in emergency medicine

      Marilyn McCullum, RN | Conditions
    • Women in health care leadership: Navigating competition and mentorship

      Sarah White, APRN | Conditions
    • Senior financial scams: a guide for primary care physicians

      John C. Hagan III, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...